* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Neurology Evaluation in the ED
Survey
Document related concepts
Transcript
Neurology Evaluation in the ED Nicholas Cascone, PA-C Components of Neuro Evaluation in ED • Mental Status – emotional and intellectual function – Thought process – Mood – Insight – Sensorium – Attention – Memory, short and long-term Components of Neuro Evaluation in ED • Glasgow Coma Scale – measure of sensorium/consciousness – Eye opening: • • • • 4 = spontaneous 3 = opens to speech 2 = opens to pain 1 = none – Verbal response: • • • • • 5 = alert, oriented 4 = disoriented but verbal 3 = nonsensical 2 = moans/unintelligible speech 1 = none Components of Neuro Evaluation in ED • Glasgow Coma Scale (cont’d) – Motor response • • • • • • 6 = follows commands 5 = localizes pain 4 = withdraws from pain 3 = decorticate – flexion 2 = decerebrate – extension 1 = none Components of Neuro Evaluation in ED • Higher cerebral function – Language • Dysarthria – mechanical disorder of speech from weakness of facial/oral muscles • Dysphasia – problem with language of cortical/subcortical origin – Fluent (Wernicke’s) or nonfluent (Broca’s) – Comprehension – tested by ability to follow commands Components of Neuro Evaluation in ED • Cranial nerves – I – rarely tested – II/III – direct/indirect pupillary response – III/IV/VI – extraocular muscle movements – V/VII – corneal reflex – VIII – hearing, balance – IX/X – gag reflex – XI – shoulder shrug – XII – tongue protrusion Components of Neuro Evaluation in ED • Sensory exam – Touch in all extremities – If negative, test proprioception or vibration sense – Further investigation involves testing individual dermatomes to localize lesions Components of Neuro Evaluation in ED • Motor system – Muscle tone – passive movement of muscle groups with patient not resisting – Muscle bulk – atrophy, wasting – Muscle strength – 0-4 scale, 0=complete paresis, 1=minimal contraction, 2=active movement when gravity counteracted, 3=movement against gravity only, 4=movement against resistance – Reflexes, Babinski response Components of Neuro Evaluation in ED • Cerebellar testing – Posture, truncal movements test central cerebellum – Appendicular movements test lateral cerebellum – Dysdiadokokinesis – inability to execute rapidly alternating movements Components of Neuro Evaluation in ED • Gait and station – Most important neurological test – Watch as patient sits upright, rises, stands, walks, turns, heel walks, toe walks – Gait disturbance examples • Ataxic – wide-based, unsteady, irregular steps, inability to negotiate barriers; cerebellar lesions • Apraxic – cannot initiate gait; nondominant hemispheric lesions • Equine – high step present due to foot drop; peroneal muscle weakness • Festination – narrow-based, shuffling; Parkinsonism • Waddling – weakness of lower trunk/pelvic girdle Introduction to Psychiatric Emergencies Nicholas Cascone, PA-C Psychiatric Presentations in the ED • Estimated that up to 1/3 of ED patients have a psychiatric diagnosis • ED task: to evaluate patient’s risk of harm to self and/or others • Psychiatric Dx accomplished through criteria defined in DSM-IV • Psychiatric evaluation includes five axes Axis I disorders in ED • Cognitive disorders – Dementia • Hallmark is cognitive deficit, including memory, abstraction, judgment, language, spatial ability – Delirium • Hallmark is clouding of consciousness, reduction of awareness of external environment, loss of alertness Axis I disorders in ED • Substance-Induced Disorders – Intoxication • Recent ingestion of exogenous substance producing maladaptive behavior, impairment of judgment, perception, attention, emotional control • Usually Dx by laboratory tests – Withdrawal • Syndromes vary according to substance of abuse • Usually Dx by identification of withdrawal syndrome and evidence of recent use Axis I disorders in ED • Psychotic disorders present to the ED due to: • Exacerbation of chronic psychosis from stress or noncompliance with medications • Side effects of antipsychotic medications • Suicidality • Violence directed towards self or others • Chronic psychosis leads to disregard for other medical conditions, precipitating need for emergency care Axis I disorders in ED • Mood disorders present in the ED due to: – Suicidality in depressive disorders – Mania in bipolar disorders causing erratic behavior or overt psychosis • Anxiety disorders present in the ED due to: – Panic disorder mimicking angina/MI – Violent/impulsive behaviors in PTSD Axis I disorders in ED • Somatoform disorders present in the ED due to: – Conversion disorder presenting with sudden neurological deficit – Hypochondriasis presenting with somatic illusion of serious illness – Factitious disorders/malingerers presenting in ED with fake/self-created symptoms Axis I disorders in ED • Personality disorders frequently seen in ED: – Antisocial personality disorder • Violence • Criminality • Substance abuse – Borderline personality disorder • Suicidality • Substance abuse Emergency Psychiatric Evaluation • History – obtain from patient and collaterals – Changes in behavior – Acute stressors – Previous psychiatric diagnoses/treatment • Neurologic symptoms – Dizziness, syncope, disorientation, confusion, loss of consciousness, headaches, difficulty with speech/routine tasks Emergency Psychiatric Evaluation • Other medical comorbidities – Fever, head trauma, HIV, exposure/ingestion of toxins • Medication history: benzodiazepines, stimulants, antipsychotics, anticonvulsants, anticholinergics, steroids, β-blockers, fluoroquinolones, opioids, salicylates, SSRIs, thiazide diuretics, antiparkinsonian agents • Drug history: alcohol, PCP, LSD, amphetamines, cocaine, barbiturates Emergency Psychiatric Evaluation • Mini Mental Status Exam (MMSE) • Complete physical exam – Abnormal vital signs should not be ascribed to stress/anxiety – Trauma signs – Neuro exam • Laboratory investigations – Minimally, urine toxicology and blood alcohol Altered Mental Status in the ED Nicholas Cascone, PA-C Delerium • Transient disorder of attention and cognition – Distortion of attention, perception, thinking, memory – Reduced alertness – Activity level may increase or decrease – Sleep/wake cycle disrupted – “sundowning” – Psychosis may be present; hallucinations tend to be visual Delerium - Causes • Infection: pneumonia, UTI, meningoencephalitis, sepsis • Metabolic: hypoglycemia, electrolyte abnormalities, hepatic encephalopathy, thyroid disorder • Neurological: stroke/TIA, seizure/post-ictal state, SAH, subdural hematoma, space-occupying lesion • Cardiopulmonary: CHF, MI, PE, hypoxia • Drug-related: drug/EtOH withdrawal, antihistamines, antiparkinson agents, antiemetics, antidepressants, antipsychotics, sedative-hypnotics, narcotic analgesics, antispasmodics/muscle relaxants, digoxin Delerium – evaluation • History from collaterals – Acute onset – Fluctuating severity – Exacerbation at night • Medication history – Medication side effects/toxicity can be observed in elderly patients at normally safe doses • Physical examination – Directed at discovering underlying process • Labs – Electrolytes, LFTs, kidney function, urinalysis/tox,CXR Delerium – Management • Tx directed at underlying cause(s) – Environment: adequate lighting, psychosocial support, reduced stimulus – Sedation to relieve agitation – Majority of patients will be hospitalized Dementia • Memory and cognitive impairment of gradual onset – Early: memory loss, naming problems, forgetting items – Middle: loss of reading, loss of social skills, spatial/direction problems – Late: disorientation, loss of self-care, personality changes Dementia – causes • Degenerative – Alzheimer’s, Huntington’s, Parkinson’s • Vascular – multiple infarcts, hypoperfusion, subdural hematoma, SAH • Infectious – meningoencephalities, neurosyphilis • Metabolic – B12/folate deficiency, thyroid disease, uremia • Psychiatric – depression • Inflammatory – SLE, demyelinating disease • Neoplastic – primary tumors/metastasis, pareneoplastic syndromes • Other – trauma,toxins (EtOH, medications), hydrocephalus Dementia – evaluation • History from patient and collaterals – Course of progression • Acute onset of symptoms suggests reversible process • Specific dates of worsening associated with vascular dementia – Family history: some causes of dementia are inherited (e.g., Huntington’s) • Physical exam – Directed at associated causes – examples: • Focal neurologic signs suggest vascular dementia or space-occupying lesion • Extrapyramidal signs suggest Parkinson’s • Labs – CBC, electrolytes, glucose, calcium, kidney function, LFTs, TFTs, B12 – CT/MRI Dementia – treatment in ED • Environmental/psychosocial interventions • Antipsychotic medications for those with persistent psychotic features or dangerous/extremely disruptive behaviors • Admission: – – – – – Patients with superimposed delerium Treatable causes of dementia Comorbid medical problems Rapid progression Unsafe/uncertain home situation Special Psychiatric Emergency Presentations Nicholas Cascone, PA-C Emergencies related to psych medications • Antipsychotics side effects – Akathisia responds to β-blocker therapy such as propranolol – Dystonia (torticollis, oculogyric crises, etc.) respond to anticholinergics (e.g. benztropine, diphenhydramine) – Parkinsonism requires dose reduction and anticholinergic therapy as above – Neuroleptic malignant syndrome: emergency presentation with rigidity, fever, tachycardia, BP lability, and altered mental status – discontinue antipsychotic and give dantrolene or bromocriptine, hydration, supportive treatment in intensive care setting Emergencies related to psych medications • Benzodiazepines – Used frequently in the ED for anxiolysis or sedation • Anxiolytics: alprazolam (Xanax®), lorazepam (Ativan®), clonazepam (Klonopin®) • Longer-acting anxiolytics/mild sedatives: diazepam (Valium®), chlordiazepoxide (Librium®) • Sedative-hypnotics: temazepam (Restoril®), triazolam (Halcion®), flurazepam (Dalmane®) – Overdose is treated with flumazenil – Paradoxical response requires discontinuation Anorexia nervosa • Dx by usual signs and symptoms – BMI 16, < 85% of expected weight for height – Unexplained primary amenorrhea – Derangement of body image • ED treatment: – Volume repletion – Correction of electrolytes – Aggressive refeeding leads to hypertonic dehydration, hypernatremia, pancreatitis Anorexia nervosa • Criteria for hospitalization: – Weight loss of 30% or more in 3 months – Severe metabolic disturbance – Suicidality – Failure to maintain outpatient weight contract – Family crisis or denial – Severe bingeing and purging – Need to initiate therapy (psychotherapy, family therapy, pharmacotherapy) Panic attack • Symptoms – – – – – – – – – – – – Palpitations/tachycardia Chest pain/pressure SOB/smothering Diaphoresis Tremor Choking sensation/globus Nausea/abdominal complaints Dizziness/lightheadedness/syncope Paresthesia Chills/hot flashes Fear of: going crazy, loss of control, dying, syncope Derealization/depersonalization Panic attack – medical differential • Cardiovascular: angina, MI, MVP, PACs • Pulmonary: angina, PE, hyperventilation • Endocrine: hyperthyroid, hypoglycemia, pheochromocytoma, Cushing’s • Neurological: stroke/TIA, partial seizure, migraine, Ménière’s • Drugs/medications: caffeine, cocaine, thyroid meds, SSRIs, cannabis, steroids, β-agonists, triptans, nicotine, hallucinogens, anticholinergics • Withdrawal syndromes: alcohol, barbiturates, benzodiazepines, opiates Panic attack – treatment • In ED: benzodiazepines • Referrals – Psychotherapy – cognitive-behavioral – Psychiatry • SSRI • Buspirone • Short-term “bridging” benzodiazepines Emergencies involving alcohol • Trauma – assault, MVA, other injuries – 25% of assaults involve alcohol – 45% of fatal MVAs involve alcohol – Head trauma often overlooked when presenting with alcohol intoxication • Obtain CT of head when: – History of head injury – No improvement in 3 hours – Worsening of mental status while under observation Emergencies involving alcohol • Withdrawal – Four steps of alcohol withdrawal • 6 – 8 hours since last drink: autonomic hyperactivity – tachycardia, diaphoresis, tremor • 24 hours since last drink: tactile and visual hallucinations • 24 – 48 hours since last drink: motor seizures • 3 – 5 days since last drink: delerium tremens – altered mental status, convulsive seizures, 5 – 15% mortality Emergencies involving alcohol • Treatment of alcohol withdrawal – Fluid resuscitation with D5NS or D5LR and thiamine (100 mg/L) – Patient placed in a quiet area with minimal stimulation – Lorazepam 2 – 4 mg IV q 15-30 minutes until light sedation is achieved – MgSO4: 4 g IV in 1 – 2 hours – For pts with seizures: • CT indicated if head trauma, focal seizure, persistent post-ictal defect in consciousness Emergencies involving alcohol • Criteria for admission – Medical complications such as CHF, infection – More than 8 mg of lorazepam needed • Referral for treatment of alcoholism Tests for conversion disorder/ malingering • Sensation – Yes/no test: pt closes eyes and responds yes/no to touch stimulus – “no” response favors conversion – Bowlus & Currier test: • pt extends crossed arms, thumbs down, palms touching, interlocking fingers, arms then rotated towards chest • False response to sensory stimulus difficult d/t distortion of position – “Strength” test: pt closes eyes and moves touched finger to assess “strength”. True sensory loss would not allow pt to determine which finger is being tested Tests for conversion disorder/ malingering • Pain – Gray test of abdominal pain • With psychological pain, pt closes eyes during palpation • With organic pain, pt watches palpation so they can guard tender areas • Motor – Drop test: “paralyzed” extremity dropped from above the face will miss it – Thigh adductor test: examiner places hands against inner thighs of patient. Pt is told to adduct normal leg against resistance. In pseudoparalysis, other leg will also adduct – Hoover test: examiner cups both heels of patient. Pt is told to elevate normal leg. In pseudoparalysis, other leg will push downward. Pt is told to elevate weak leg. Absence of downward pressure indicates noncompliance. Tests for conversion disorder/ malingering • Coma – Corneal reflexes retained in awake patient • Seizure – Resistance to covering of mouth & nose indicates pseudoseizure – Palpation of abdominal muscles reveals lack of contraction in pseudoseizure • Blindness – Opticokinesis: tape with alternating black and white sections pulled laterally in front of patient’s open eyes induces nystagmus in patient with intact vision Headache/Vertigo in the ED Nicholas Cascone, PA-C Headache in the ED • 4% of all ED visits are due to headache – 4% of these headache visits have serious or secondary pathology • Objectives of evaluation: – Appropriately select patients for emergency investigation when critical secondary causes are present – Provide effective treatment for primary and benign secondary headaches Evaluation of Headache in ED • History – Pattern – worst ever, first severe, steady worsening, differences from prior headaches – Onset – sudden headaches that begin during exertion – up to 25% of such HA are SAH – Associated symptoms – dizziness, nausea, confusion, LOC, fever, neck pain/stiffness, visual changes, seizure Evaluation of Headache in ED • History (cont’d.) – Medical history – trauma, previous lumbar puncture, use of nitrates, MAOIs, exposure to toxics (e.g., CO) – Family history – migraines, SAH run in families Evaluation of Headache in ED • Physical examination – Temperature, blood pressure – Palpate sinuses, temporal artery, temporomandibular joint – Eye exam for acute glaucoma, fundoscopy for signs of hypertension, papilledema – Thorough neurological exam • Labs – CT scan, lumbar puncture if indicated Killer Headaches • Subarachnoid hemorrhage – More common in women – Severe, constant occipitonuchal HA, “worst in my life” – Often presents suddenly, with vomiting and alteration of consciousness – History may indicate activities which raise blood pressure (e.g., intercourse, defecation, coughing) Killer Headaches • Subarachnoid hemorrhage (cont’d) – Dx: plain CT 93% sensitivity within 24 h of onset – If CT nondiagnostic, LP • Xanthochromia on spectrophotometry nearly 100% sensitive • Naked-eye detection only 50% sensitive – Tx: angiogram and surgery consult, nimodipine, prohylactic phenytoin, antiemetics, decrease BP if elevated Killer Headaches • Meningitis – Occipitonuchal headache with fever, meningeal signs, altered consciousness – Dx: immediate LP in pts without neurological signs, normal LOC and no papilledema • If LP delayed and bacterial meningitis suspected, initiate empiric antibiotic tx Killer Headaches • Subdural hematoma – History of remote trauma with headache – High risk patients: • Anticoagulation • Chronic alcoholics • Elderly patients – If plain CT nondiagnostic, contrast CT or MRI – Tx: surgery consult Killer Headaches • Brain tumor – Headache may be unilateral/bilateral, intermittent/continuous – Classic presentation is headache with vomiting, worse upon arising – Reliable pt with no neuro findings and no papilledema can follow-up as outpatient within 24 hours (worst at night and awakens pt) Other Headaches • Secondary headaches – – – – – – Temporal arteritis Acute glaucoma Hypertensive headache Sinusitis Post-LP Drug-related/toxic • Primary headaches – Migraine – Cluster – Tension Vertigo • Sensation of movement where none exists • Peripheral causes vs. central causes – peripheral causes usually benign, central causes can be urgent – Peripheral vertigo: sudden onset, intense, paroxysmal, aggravated by position/movement, associated with nausea or hearing loss/tinnitus, horizontal nystagmus, fatiguable, CNS signs absent – Central vertigo: any onset, ill-defined, constant, variable association with position/movement/nausea, not associated with hearing loss/tinnitus, vertical nystagmus, not fatiguable, CNS signs usually present Vertigo – causes • Peripheral causes – BPPV, Ménière’s disease, labrynthitis, ototoxicity, head injury • Central causes – Cerebellar stroke, VBI, MS, migraine, epilepsy, neoplasm • General causes – Anemia, EtOH intoxication, hypoglycemia, renal failure, thyroid disease Vertigo - evaluation • History – Description of sensation – vertigo, syncope/near-syncope, disequilibrium – Onset – Associated symptoms • Peripheral associated with nausea/vomiting, tinnitus/hearing loss, photophobia • Central associated with diplopia, dysarthria, visual abnormalities • Headache suggests migraine or space-occupying lesion • Head trauma, medications Vertigo - evaluation • Physical exam – Ear: otoscopy, hearing exam, Webber/Rinne – Eye: nystagmus, EOMs – Heart rate, rhythm, murmurs – Cranial nerves – Cerebellar testing – Proprioception/vibration – Test patients with near-syncope for orthostasis Vertigo – evaluation • Dix-Hallpike position testing: pt seated upright, head turned 45° to right, swiftly reclined with head tilted backward additional 45°; repeated with head turned to left – Warn pt that test may produce vertigo – Positive test indicated by nystagmus; positive side is side with lesion – Contraindicated in patients with carotid bruits, cervical spondylosis Vertigo – evaluation • Labs – Depend on suspected etiology • • • • Labrynthitis: CBC, blood culture Head injury: CT for bleeding Near-syncope: ECG, cardiac monitoring, CBC for anemia Electrolytes, glucose, kidney function, thyroid Vertigo – symptomatic treatment • Pharmacotherapy – Scopolamine – Antihistamines – diphenhydramine (Benadryl®), meclizine (Antivert®) – Neuroleptics – metoclopramide (Reglan®), promethazine (Phenergan®) – Benzodiazepines for anxiety – diazepam (Valium®), clonazepam (Klonopin®) Seizures in the ED Nicholas Cascone, PA-C Seizures in the ED • Episode of abnormal neurologic function caused by inappropriate electrical discharge of neurons • 6 – 10% of individuals experience a seizure, 1 – 2% have recurrent seizures • Peak incidence among age < 20, second peak among age > 60 Classification of seizure • Classification – Partial: unilateral clonic/tonic movements, sensory hallucinations (tactile, olfactory, gustatory), visual symptoms • Simple (no alteration of consciousness) vs. complex (loss of consciousness) – Generalized: loss of consciousness with or without motor manifestations • Tonic-clonic • Absence • Myoclonus and others Seizure – evaluation • History – Aura, onset, duration, post-ictal condition – If known epileptic: precipitants, medication Hx, sleep Hx, infection – If no previous history: head injury, headache, drug/alcohol use/abuse • Previous behaviors that may point to unrecognized seizures: enuresis, blank spells, unexplained injury, tongue biting Seizure – evaluation • Physical exam – Injuries to head/spine – Fractures, dislocations, bruising, tongue lacerations – Neuro exam • Labs – Glucose, electrolytes, Ca, Mg, hCG, tox screen, UA for rhabodmyolisis – Wide anion gap metabolic (lactic) acidosis up to 1 hour after event – Anticonvulsant levels – First seizure: non-contrast CT to rule out structural lesion Seizure – treatment in ED • Seizing patient – expectant management – Clear area to prevent injury – Turn to side to prevent aspiration – After seizure, insure airway • Patient with previous seizures: – Eliminate precipitants – Supplement anticonvulsant levels if necessary Special cases • Seizure in pregnancy – Epilepsy in pregnancy: antiepileptics are potentially teratogenic, but uncontrolled seizures also potentially dangerous • Risk to fetus minimized with single-drug therapy, folate and vitamin K supplementation – Eclampsia: seziures beyond 20 weeks, with HTN, edema, proteinuria; may present with HA, blurry vision, epigastric pain, hyperreflexia • Manage with MgSO4, definitie treatment is delivery Special cases • Seizure associated with alcohol – Missed doses of anticonvulsant, sleep deprivation, propensity for head injury, toxic coingestions, electrolyte derangement – Seizures in alcohol withdrawal: • No anticonvulsant if first seizure, benzodiazepines and referral for detoxification Special cases • Status epilepticus – More than 5 minutes of seizure activity – 2 or more seizure episodes without full recovery of consciousness between • Management of SE – – – – – Large-bore IV, intubation, O2 Dextrose, thiamine, magnesium if needed IV lorazepam, then IV phenytoin IV phenobarbital if phenytoin fails General anesthesia with midazolam/propofal/pentoparbital if phenobarbital fails CNS Infection Nicholas Cascone, PA-C Meningitis • Infection in subarachnoid space – bacterial, viral, fungal – Noninfectious meningitis from neoplastic, toxic, autoimmune processes • In ED, early suspicion and empiric treatment is critical • Pt presents with fever, HA, neck pain/stiffness, photophobia, AMS Meningitis – evaluation • History – Living conditions: barracks, dormitories, day care centers – Head trauma/neurosurgery – Immunocompromise: asplenism, steroids, HIV • Examination – – – – – Assess meningeal signs: Brudzinski, Kernig Skin: petechial rash of N. meningitidis Assess sinuses, ears for evidence of primary infection Fundoscopy for papilledema Neurological exam Meningitis – evaluation • Labs – Lumbar puncture when safe – CSF analysis: • Bacterial: ↑↑ opening pressure, ↑↑ WBCs, ↑ PMNs, ↑ protein, ↓ glucose • Viral: ↑ opening pressure, ↑ WBCs, normal PMNs, normal protein, normal glucose • Fungal: ↑↑ opening pressure, ↑ WBCs, normal PMNs, ↑ protein, ↓ glucose Meningitis – management • Initiate empiric antibiotic treatment – does not affect results of LP if performed within 2 hours – Neonates: ceftriaxone for S. pneumoniae and E. coli – Infants, children, adults: ceftriaxone and vancomycin for S. pneumoniae and N. meningitidis – Immunocompromised patients, adults over 50: add ampicillin for L. monocytogenes Meningitis – management • • • • • Anti-inflammatory Antipyretic Monitor sodium to avoid SIADH Phenytoin loading for seizures Cerebral edema – elevate head, hyperventilate, administer mannitol • Chemoprophylaxis for close contacts of patients with N. meningitidis or H. influenzae – Rifampin, ceftriaxone or ciprofloxacin Encephalitis • Viral infection of brain parenchyma – West Nile virus – Arboviruses – Rabies • Presentation: meningeal signs with cognitive deficit, seizure, psych symptoms, movement disorder • Patients should be admitted Cerebrovascular Events in the ED Nicholas Cascone, PA-C Cerebrovascular Events in the ED • Stroke – – – – – Interruption of blood supply to focal region of the brain 3rd leading cause of death in US 20% of stroke patients die within the first year One-third of stroke patients are under the age of 65 Early diagnosis and treatment of patients arriving at ED with stroke lessens impact of disease Cerebrovascular Events in the ED • Ischemic stroke syndromes – Anterior cerebral artery: LE > UE weakness, perseveration, motor slowing – Middle cerebral artery: face/UE>LE, aphasia if in dominant hemisphere, apraxia, homonymous hemianopia – Posterior cerebral artery: vision loss, paresthesia, sensory loss, dizziness, N/V – Cerebellar: “drop attack”, vertigo, HA, nausea, neck pain, cranial nerve abnormalities Evaluation of Stroke in the ED • History – Hx of HTN, CAD, DM suggests thrombotic stroke – Hx of A fib, mechanical/replacement valves, MI suggests embolic stroke – TIAs: prior TIA in same vascular distribution suggests thrombosis, multiple TIAs in different distributions suggest embolism Evaluation of Stroke in the ED • History (cont’d) – Onset: sudden (embolic or hemorrhagic) vs. stuttering/waxing and waning (thrombotic or hypoperfusion) – Onset during straining/coughing suggests rupture of aneurysm – Associated complaints: HA (hemorrhagic), N/V, trauma – Recent neck injury: MVA, chiropractic adjustment, sportsrelated suggests carotid dissection Evaluation of Stroke in the ED • Physical exam – Temperature – Skin signs of embolism (Janeway lesions, Osler nodes), bleeding dyscrasias (petechiae, ecchymosis) – Fundoscopy (papilledema, hypertensive retinopathy) – Cardiopulmonary auscultation (S3, rales, carotid bruits) Evaluation of Stroke in the ED • Labs – Emergent non-contrast CT distinguishes hemorrhagic stroke from ischemic – EKG – CBC, coagulation studies, type & screen, electrolytes, glucose, toxicology, cardiac enzymes Management of Stroke in the ED • O2, elevate head, cardiac monitor, IV access • Volume repletion, antipyretic • Manage hypertension only if severe – higher pressure may help save penumbra of stroke • Secondary prevention: antiplatelet agent, anticoagulation Management of Stroke in the ED • Thrombolytic treatment – Contraindications • Absolute: previous hemorrhagic stroke, any other stroke in past year, suspected dissection, pericarditis, intracranial tumor • Relative: BP over 180/110, chronic severe hypertension, age over 75, anticoagulation, trauma/internal bleeding within 4 weeks, surgery within 3 weeks, peptic ulcer, hemodynamically unstable, pregnant Violence and Suicide in the ED Nicholas Cascone, PA-C Violence in the ED • 50% of all health care providers will be involved in violence during their careers • ED patients/collaterals are frequently fatigued, hungry, frustrated, anxious, higher proportion of substance abuse • 5% of patients presenting to the ED carry weapons • Most perpetrators of violence in ED are males with Hx of substance abuse – Education, ethnicity, marital status, diagnosis are not reliable predictors • Factors predisposing ED to violence: long waiting times, staff shortages, overcrowding, patient expectations, patient financial problems Violence in the ED • Prodrome of violence: – Phase 1: Anxiety • Movement with no purpose other than to expend energy – Pacing, wringing of hands, clenching of fists, unwillingness to stay in waiting/treatment area • Loud, pressured speech • Appropriate response: develop rapport, listen to and address concerns Violence in the ED – Phase 2: Defensiveness • Verbal abuse, profanity – Directed towards staff or others in the department – Statements regarding age, weight, heritage, gender • Body posturing • Appropriate response: – Set simple, clear, enforceable and consistent limits – Offer patient reasonable choices – Isolate patient and provide show of force by uniformed security personnel Violence in the ED – Phase 3: Physical Aggression • Total loss of control • Physical aggression directed towards staff or others in the department • Aggressive patients must be confronted and controlled physically for the safety of themselves, other patients, visitors and staff – Requires personnel skilled in control techniques – Should never be attempted by unskilled personnel or singlehandedly Restraint in the ED • Review your organization’s rules for restraint • JCAHO policy: – Only licensed independent practitioner (LIPs) can order restraint • Written order must include type of restraint, reason for restraint, time limit for restraint – If LIP is not available, restraint may be initiated by caregivers but LIP must perform face-to-face evaluation within 1 hour Restraint in the ED – Restrained patients must be evaluated q15min, including examinations for: • • • • • • • • Injury Hydration/nutrition Circulation/ROM Vital signs Hygiene/elimination Comfort Psychological status Readiness for discontinuation of restraint Restraint in the ED – Reason for restraint must be explained to the patient – Patient in restraint should never be abandoned – No patient who has been restrained should be allowed to leave the ED AMA – Patients brought to the ED in restraint should remain in restraint until thoroughly assessed for threat of violence and medical condition Medical management of violent behavior • Used when patients are too violent, even under restraint to perform adequate evaluation – Antipsychotics: haloperidol (Haldol®) 5 mg IM q3045min – Benzodiazepines: lorazepam (Ativan®) 2-4 mg IM q30min – More effective when used in combination; more rapid onset and fewer injections needed Suicide • Suicidality is associated with severe depression, isolation, loss, stressful life events • Providers’ negative attitudes towards those who attempt suicide exacerbate patient risk Risk of suicide • High risk – Male – Separated/widowed divorced – Chaotic/conflictual family, FHx of suicide – Unemployed – Recent conflict or loss – Weak or no religious suicide taboo • Low risk – Female – Married – Stable family – Employed – Stable relationships – Strong religious taboo against suicide Risk of suicide • High risk (cont’d) – Acute/chronic illness – Excessive drug/alcohol use – Depression/bipolar/ schizophrenia/panic – Disruptive behavior – Helplessness/ hopelessness – Frequent, intense, prolonged suicidal ideation • Low risk (cont’d) – – – – – Stable health Little or no drug/alcohol use No axis I mental disorders Directable Hopeful, future-oriented – Infrequent, transient ideation Risk of suicide • High risk (con’td) – Prior suicide attempts – High-risk, dangerous attempts – Realistic plan – Guilt regarding suicide ideation – Lack of concern regarding attempts – Social isolation • Low risk (cont’d) – No prior attempts – Attempts with high likelihood of rescue – No plan – Embarrassment regarding ideation – Insight regarding affect on others – Social integration Markers for ongoing risk • • • • • Psychosis Hopelessness/helplessness Exhaustion Lack of anger/remorse/embarassment History of prior attempts, especially high-risk attempts • Continuing intention to die Criteria for discharge • • • • • • • • • Medically stable Pt agrees to return to ED if suicidal intent recurs Not intoxicated, delerious, demented Means of self-harm has been removed Treatment of psychiatric diagnoses has been arranged Acute precipitants of suicide have been addressed/resolved Patient and family agrees to follow-through on treatment Patient’s caregivers/family agrees to discharge plan “No harm” contract has been established • Document all criteria • If in doubt, obtain psychiatric consult or hospitalize